148 related articles for article (PubMed ID: 38666045)
1. Determinants of Bone Mineral Density in Iranian Women with Polycystic Ovary Syndrome.
Karimi F; Mardani P
Int J Endocrinol Metab; 2023 Oct; 21(4):e137594. PubMed ID: 38666045
[TBL] [Abstract][Full Text] [Related]
2. Bone mineral density in women with polycystic ovary syndrome.
Katulski K; Slawek S; Czyzyk A; Podfigurna-Stopa A; Paczkowska K; Ignaszak N; Podkowa N; Meczekalski B
J Endocrinol Invest; 2014 Dec; 37(12):1219-24. PubMed ID: 25245338
[TBL] [Abstract][Full Text] [Related]
3. Bone Mineral Density is Unaltered in Women with Polycystic Ovary Syndrome.
Ganie MA; Chakraborty S; Sehgal A; Sreejith M; Kandasamy D; Jana M; Rashid A
Horm Metab Res; 2018 Oct; 50(10):754-760. PubMed ID: 30312986
[TBL] [Abstract][Full Text] [Related]
4. Effects of Metformin Treatment on Soluble Leptin Receptor Levels in Women with Polycystic Ovary Syndrome.
Liu RB; Liu Y; Lv LQ; Xiao W; Gong C; Yue JX
Curr Med Sci; 2019 Aug; 39(4):609-614. PubMed ID: 31346998
[TBL] [Abstract][Full Text] [Related]
5. Relationship between bone mineral density and insulin resistance in polycystic ovary syndrome.
Yüksel O; Dökmetaş HS; Topcu S; Erselcan T; Sencan M
J Bone Miner Metab; 2001; 19(4):257-62. PubMed ID: 11448019
[TBL] [Abstract][Full Text] [Related]
6. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
7. Determinants of low bone mineral density in premenopausal polycystic ovary syndrome patients.
Karadağ C; Yoldemir T; Gogas Yavuz D
Gynecol Endocrinol; 2017 Mar; 33(3):234-237. PubMed ID: 27908213
[TBL] [Abstract][Full Text] [Related]
8. Women With Polycystic Ovary Syndrome Have Comparable Hip Bone Geometry to Age-Matched Control Women.
McBreairty LE; Zello GA; Gordon JJ; Serrao SB; Pierson RA; Chizen DR; Chilibeck PD
J Clin Densitom; 2018; 21(1):54-60. PubMed ID: 28034591
[TBL] [Abstract][Full Text] [Related]
9. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
Singh S; Akhtar N; Ahmad J
Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
[TBL] [Abstract][Full Text] [Related]
10. Intrinsic factors rather than vitamin D deficiency are related to insulin resistance in lean women with polycystic ovary syndrome.
Sahin S; Eroglu M; Selcuk S; Turkgeldi L; Kozali S; Davutoglu S; Muhcu M
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2851-6. PubMed ID: 25339479
[TBL] [Abstract][Full Text] [Related]
11. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
Holte J; Bergh T; Gennarelli G; Wide L
Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
[TBL] [Abstract][Full Text] [Related]
12. The Degree of Menstrual Disturbance Is Associated With the Severity of Insulin Resistance in PCOS.
Li X; Yang D; Pan P; Azziz R; Yang D; Cheng Y; Zhao X
Front Endocrinol (Lausanne); 2022; 13():873726. PubMed ID: 35769085
[TBL] [Abstract][Full Text] [Related]
13. Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women.
El-Eshmawy MM; Ibrahim A; Bahriz R; Shams-Eldin N; Mahsoub N
BMC Endocr Disord; 2022 Dec; 22(1):315. PubMed ID: 36514085
[TBL] [Abstract][Full Text] [Related]
14. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
Ardawi MS; Rouzi AA
Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
[TBL] [Abstract][Full Text] [Related]
15. Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome.
Zhang H; Wang W; Zhao J; Jiao P; Zeng L; Zhang H; Zhao Y; Shi L; Hu H; Luo L; Fukuzawa I; Li D; Li R; Qiao J
Front Endocrinol (Lausanne); 2022; 13():1085656. PubMed ID: 36699018
[TBL] [Abstract][Full Text] [Related]
16. The association of bone mineral density with insulin resistance in patients with polycystic ovary syndrome.
Noyan V; Yucel A; Sagsoz N
Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):200-5. PubMed ID: 15262356
[TBL] [Abstract][Full Text] [Related]
17. Obesity and Insulin Resistance, Not Polycystic Ovary Syndrome, Are Independent Predictors of Bone Mineral Density in Adolescents and Young Women.
Pereira-Eshraghi CF; Chiuzan C; Zhang Y; Tao RH; McCann M; Neugut YD; Printz A; Fennoy I; Cree-Green M; Oberfield SE; Sopher AB
Horm Res Paediatr; 2019; 92(6):365-371. PubMed ID: 32348991
[TBL] [Abstract][Full Text] [Related]
18. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
Pehlivanov B; Mitkov M
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
[TBL] [Abstract][Full Text] [Related]
19. Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
Pangaribuan B; Yusuf I; Mansyur M; Wijaya A
Ther Adv Endocrinol Metab; 2011 Dec; 2(6):235-45. PubMed ID: 23148188
[TBL] [Abstract][Full Text] [Related]
20. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]